Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01392092 · ClinicalTrials.gov registry record
Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC)
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 16
- Enrollment target
NCT01392092: Completed study, sponsored by Wayne State University.
NCT01392092 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01392092 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
N-acetylcysteine (NAC) is a medication that the Food and Drug Administration (FDA) has approved for several medical uses, such as dissolving mucus in patients with breathing problems, treating overdose from acetaminophen (Tylenol), and protecting the kidneys from toxic substances. Some recent studies suggest that NAC could be useful in the treatment of other disorders including addictions. One purpose of this study is to determine whether NAC alters the level of brain glutamate (a chemical that excites brain cells). The other main purpose is to determine whether NAC affects how much cocaine people use.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-07 |
| Est. Completion | 2017-06 |
What the finished NCT01392092 record still lists
NCT01392092 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01392092 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01392092 about?
NCT01392092 is a clinical study titled "Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC)". N-acetylcysteine (NAC) is a medication that the Food and Drug Administration (FDA) has approved for several medical uses, such as dissolving mucus in patients with breathing problems, treating overdose from acetaminophen (Tylenol), and protecting the kidneys from toxic substances. Some recent studi...
What is the current status of trial NCT01392092?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2011-07. Estimated completion is 2017-06.
Who is sponsoring clinical trial NCT01392092?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia